Willamette Valley Cancer Center is a clinical research site located in Eugene, Oregon, United States 97401.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Willamette Valley Cancer Center has participated in 32 clinical trials with 8 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.
Sponsors: Astellas Pharma Inc, Gynecologic Oncology Group, US Oncology Research.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Willamette Valley Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Willamette Valley Cancer Center has 32 clinical trials on record, with 8 currently active. Their work covers Chronic Lymphocytic Leukemia, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.
Yes — Willamette Valley Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.